Onabotulinumtoxin A for Treating Overactive/Poor Compliant Bladders in Children and Adolescents with Neurogenic Bladder Secondary to Myelomeningocele

This retrospective study was performed to verify the efficacy and safety of Onabotulinumtoxin A (BTX-A) in treating children with neurogenic bladder (NB) secondary to myelomeningocele (MMC) with detrusor overactivity/low compliance. From January 2002 to June 2011, 47 patients out of 68 with neuropat...

Descripción completa

Detalles Bibliográficos
Autor principal: Marte, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3564065/
https://www.ncbi.nlm.nih.gov/pubmed/23274271
http://dx.doi.org/10.3390/toxins5010016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3564065/
https://www.ncbi.nlm.nih.gov/pubmed/23274271
http://dx.doi.org/10.3390/toxins5010016

Ejemplares similares